| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". | J Transl Med | 2008 | 1.77 |
| 2 | Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. | J Transl Med | 2009 | 1.31 |
| 3 | Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. | J Clin Oncol | 2005 | 1.08 |
| 4 | Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. | Gynecol Oncol | 2007 | 1.03 |
| 5 | Immune checkpoint inhibitors in clinical trials. | Chin J Cancer | 2014 | 0.98 |
| 6 | Clinical Trials Referral Resource. Clinical trials in cervical cancer. | Oncology (Williston Park) | 2003 | 0.75 |
| 7 | Cancer vaccines: is there a future? | Expert Rev Vaccines | 2004 | 0.75 |